PT796843E - Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol - Google Patents

Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol

Info

Publication number
PT796843E
PT796843E PT97104387T PT97104387T PT796843E PT 796843 E PT796843 E PT 796843E PT 97104387 T PT97104387 T PT 97104387T PT 97104387 T PT97104387 T PT 97104387T PT 796843 E PT796843 E PT 796843E
Authority
PT
Portugal
Prior art keywords
trisde
colecalciferol
dihydroxy
hydro
derivatives
Prior art date
Application number
PT97104387T
Other languages
English (en)
Inventor
Bernard Michael Hennessy
Milan Radoje Uskokovic
Jerome Anthony Iacobelli
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT796843E publication Critical patent/PT796843E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Liquid Crystal Substances (AREA)
PT97104387T 1996-03-21 1997-03-14 Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol PT796843E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1380996P 1996-03-21 1996-03-21

Publications (1)

Publication Number Publication Date
PT796843E true PT796843E (pt) 2003-09-30

Family

ID=21761865

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97104387T PT796843E (pt) 1996-03-21 1997-03-14 Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol

Country Status (30)

Country Link
EP (1) EP0796843B1 (pt)
JP (1) JP2801587B2 (pt)
KR (1) KR100240541B1 (pt)
CN (1) CN1110477C (pt)
AR (1) AR006315A1 (pt)
AT (1) ATE240941T1 (pt)
AU (1) AU708679B2 (pt)
BR (1) BR9701404A (pt)
CA (1) CA2199893C (pt)
CO (1) CO4820396A1 (pt)
CZ (1) CZ85897A3 (pt)
DE (1) DE69722064T2 (pt)
DK (1) DK0796843T3 (pt)
ES (1) ES2198512T3 (pt)
HR (1) HRP970162A2 (pt)
HU (1) HUP9700609A3 (pt)
ID (1) ID16285A (pt)
IL (1) IL120469A0 (pt)
MA (1) MA26423A1 (pt)
MX (1) MX9702139A (pt)
NO (1) NO971217L (pt)
NZ (1) NZ314424A (pt)
PE (1) PE42998A1 (pt)
PL (1) PL319070A1 (pt)
PT (1) PT796843E (pt)
SG (1) SG70589A1 (pt)
TR (1) TR199700219A3 (pt)
TW (1) TW444001B (pt)
YU (1) YU10397A (pt)
ZA (1) ZA972302B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
KR101285720B1 (ko) * 2012-03-02 2013-07-19 주식회사 유니크메디케어 여드름 개선용 조성물
KR102493627B1 (ko) 2015-11-26 2023-01-31 코웨이 주식회사 호르데닌을 유효성분으로 함유하는 피부암 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
DK0398217T3 (da) * 1989-05-18 1994-02-14 Hoffmann La Roche Dehydrocholecalciferolderivater

Also Published As

Publication number Publication date
CA2199893C (en) 2008-02-05
YU10397A (sh) 1999-07-28
CZ85897A3 (cs) 1998-04-15
EP0796843A2 (en) 1997-09-24
CN1172793A (zh) 1998-02-11
AR006315A1 (es) 1999-08-25
DE69722064D1 (de) 2003-06-26
KR970065495A (ko) 1997-10-13
CA2199893A1 (en) 1997-09-21
SG70589A1 (en) 2000-02-22
TR199700219A2 (xx) 1997-10-21
TW444001B (en) 2001-07-01
PL319070A1 (en) 1997-09-29
TR199700219A3 (tr) 1997-10-21
IL120469A0 (en) 1997-07-13
ZA972302B (en) 1997-09-22
BR9701404A (pt) 1998-11-03
CN1110477C (zh) 2003-06-04
EP0796843B1 (en) 2003-05-21
HU9700609D0 (en) 1997-05-28
JPH107651A (ja) 1998-01-13
AU708679B2 (en) 1999-08-12
MA26423A1 (fr) 2004-12-20
ATE240941T1 (de) 2003-06-15
KR100240541B1 (ko) 2000-01-15
MX9702139A (es) 1998-04-30
JP2801587B2 (ja) 1998-09-21
ID16285A (id) 1997-09-18
AU1513597A (en) 1997-09-25
DE69722064T2 (de) 2004-04-08
DK0796843T3 (da) 2003-09-15
CO4820396A1 (es) 1999-07-28
ES2198512T3 (es) 2004-02-01
PE42998A1 (es) 1998-08-11
HRP970162A2 (en) 1998-04-30
EP0796843A3 (en) 1999-04-14
NO971217D0 (no) 1997-03-17
NO971217L (no) 1997-09-22
HUP9700609A3 (en) 1999-03-01
NZ314424A (en) 1998-07-28
HUP9700609A2 (hu) 1998-07-28

Similar Documents

Publication Publication Date Title
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
PT934320E (pt) Derivados de naftiridina
PT891332E (pt) Derivados de 6-fenilpiridil-2-amina
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
DK0901474T3 (da) Arylpyrimidinderivater
NO983169L (no) Hetrosykel-kondenserte morfinoidderivater (31)
NO981946D0 (no) Imidazoquinazolin-derivater
ATE231847T1 (de) Substituierte 1,2,3,4- tetrahydronaphthalinderivate
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
BR9709065A (pt) Derivados de alquilaminobenzotiazole e-benzoxazol
IS5026A (is) 2-metoxýfenýlpíperasín afleiður
BR9708595A (pt) Utilização de derivados de 2,5- di-hidroxibenzenossulfonicos
PT931087E (pt) Novos derivados de piranosido
PT906279E (pt) Derivados de pirrol
MA26440A1 (fr) Derives de n-benzylazolium
DE69622415T2 (de) 12H-Dibenzo[d,g][1,3]dioxocin Derivate
PT796843E (pt) Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol
BR9708310A (pt) Derivados de 2-tioxotetrahidropirimidin-4-ona
BR9706980A (pt) Derivados de isooxacefem
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
PT101876A (pt) Novos derivados de 10,11-di-hidro-10-oxo-5h-dibenzo(b,f)azepina-5-carboxamida
BR9704770A (pt) Derivados de 1-carba-(detia)-cefalosporina
BR9704674A (pt) Derivados de n-benzilazólio